$ Value
$129K
Shares
10,864
Price
$12
Filed
Dec 9
Insider
Name
Richard Ronald
Title
—
CIK
0001380177
Roles
Transaction Details
Transaction Date
2025-12-05
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
113,301
Footnotes
Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12. | Represents shares of common stock sold solely to satisfy the option exercise price and applicable taxes associated with the option exercise. | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $11.88 to $11.97. | Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, as compensation for Board and Committee service. The shares underlying the options exercised were fully vested on May 22, 2025.
Filing Info
Richard Ronald's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-05 | EBS | ▼ | $86K |
| 2025-12-05 | EBS | M | $129K |
| 2025-12-05 | EBS | F | $129K |
| 2025-12-05 | EBS | ▼ | $177K |
| 2025-12-05 | EBS | M | $0 |
| 2025-04-30 | EBS | A | $0 |
| 2025-04-30 | EBS | A | $0 |
Other Insiders at EBS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FOWLER JOHN D JR | — | — | 2026-03-03 |
|
LINDAHL RICHARD S
EVP, Chief Financial Officer
|
— | — | 2026-03-05 |
|
PAPA JOSEPH C
President and CEO
|
— | — | 2026-03-05 |
|
Glessner Coleen
EVP, Quality & Ethics, and CPL
|
— | — | 2026-03-05 |
|
Williams Paul Anthony
SVP, Products Business
|
— | $34K | 2026-04-01 |
|
Hartzel William
SVP, Bioservices
|
— | — | 2026-03-05 |
|
Perl Jessica
SVP, General Counsel, Corp Sec
|
— | — | 2026-03-05 |
|
Lowry Simon C
SVP, R&D, CMO
|
— | — | 2026-03-05 |